Posted this on IHUB this morning: I have been a
Post# of 72440
I have been a strong proponent about the potential of the IPIX pipeline and have stated my opinion that it should be in the many billions of dollars.
One of the statements everybody here has heard is Leo's comment that "Big Pharma knows that we know the value of our drugs."
While it is a great line at first blush, looking deeper finds an even greater meaning to it when put into today's context.
We have been told that there are 20+ CDAs and some of them came after the San Fran convention earlier this year. Leo made the comment referenced above much earlier in 2017, thus all those CDA's that were signed since then have been signed with the BPs knowing the general price range Leo has in mind for our products. I also don't believe any prior CDAs were signed with any of the BPs not having a firm grasp on the value Leo has in mind regarding our drugs.
If Leo's valuation was way out of whack, why would a BP even take the time and effort, much less the cost, to sign a CDA? Ergo, there must be some commonality of where BP and Leo want to start negotiations regarding our products.
I am sure Leo most likely won't get all he wants, though having a number of suitors could bring about a bidding war, and I darn well know BP isn't going to get anything for as cheap as they want but IMO Leo is in a much stronger negotiating position.
I am sure most readers pay more attention to posts that try and rationalize current IPIX happenings rather than the daily rantings of doom to which we all now are so accustomed. I would say most every biotech startup mgt team would trade places with our team in a heartbeat, knowing that their chances for success would be about the best in the business.